| 000 | 01262 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250513083547.0 | ||
| 264 | 0 | _c19960208 | |
| 008 | 199602s 0 0 eng d | ||
| 022 | _a1018-8665 | ||
| 024 | 7 |
_a10.1159/000246564 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aIglesias, M E | |
| 245 | 0 | 0 |
_aFixed drug eruption secondary to ondansetron. _h[electronic resource] |
| 260 |
_bDermatology (Basel, Switzerland) _c1995 |
||
| 300 |
_a270-1 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 |
_aAntiemetics _xadverse effects |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aDrug Eruptions _xetiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperpigmentation _xchemically induced |
| 650 | 0 | 4 | _aImmunotherapy |
| 650 | 0 | 4 |
_aMelanoma _xdrug therapy |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOndansetron _xadverse effects |
| 650 | 0 | 4 |
_aSkin Neoplasms _xdrug therapy |
| 700 | 1 | _aEspaña, A | |
| 700 | 1 | _aRedondo, P | |
| 700 | 1 | _aQuintanilla, E | |
| 773 | 0 |
_tDermatology (Basel, Switzerland) _gvol. 191 _gno. 3 _gp. 270-1 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000246564 _zAvailable from publisher's website |
| 999 |
_c8534059 _d8534059 |
||